These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 33810902)
1. The safety of BCG revaccination: A systematic review. Bannister S; Sudbury E; Villanueva P; Perrett K; Curtis N Vaccine; 2021 May; 39(20):2736-2745. PubMed ID: 33810902 [TBL] [Abstract][Full Text] [Related]
2. Systematic review protocol on Bacillus Calmette-Guerin (BCG) revaccination and protection against tuberculosis. Mahasha PW; Ndwandwe DE; Mavundza EJ; Shey M; Wiysonge CS BMJ Open; 2019 Oct; 9(10):e027033. PubMed ID: 31619416 [TBL] [Abstract][Full Text] [Related]
3. Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination. Nemes E; Geldenhuys H; Rozot V; Rutkowski KT; Ratangee F; Bilek N; Mabwe S; Makhethe L; Erasmus M; Toefy A; Mulenga H; Hanekom WA; Self SG; Bekker LG; Ryall R; Gurunathan S; DiazGranados CA; Andersen P; Kromann I; Evans T; Ellis RD; Landry B; Hokey DA; Hopkins R; Ginsberg AM; Scriba TJ; Hatherill M; N Engl J Med; 2018 Jul; 379(2):138-149. PubMed ID: 29996082 [TBL] [Abstract][Full Text] [Related]
4. BCG vaccination strategies against tuberculosis: updates and perspectives. Qu M; Zhou X; Li H Hum Vaccin Immunother; 2021 Dec; 17(12):5284-5295. PubMed ID: 34856853 [TBL] [Abstract][Full Text] [Related]
5. [Adverse effects of BCG revaccination: 12 cases]. El Ouazzani H; Lamsyah H; Alioua Z; Rhorfi I; Rguibi M; Ghfir M; Abid A; Sedrati O; Alaoui-Tahiri K Ann Dermatol Venereol; 2007 Feb; 134(2):129-32. PubMed ID: 17375007 [TBL] [Abstract][Full Text] [Related]
6. First vaccination after birth: serious adverse events of Bacillus Calmette-Guérin (BCG) in real-world. Lu J; Zhang X; Xu H; Li Z Hum Vaccin Immunother; 2022 Nov; 18(5):2080443. PubMed ID: 35687363 [TBL] [Abstract][Full Text] [Related]
7. Bacillus Calmette-Guérin (BCG) vaccine adverse events in Victoria, Australia: analysis of reports to an enhanced passive surveillance system. Clothier HJ; Hosking L; Crawford NW; Russell M; Easton ML; Quinn JA; Buttery JP Drug Saf; 2015 Jan; 38(1):79-86. PubMed ID: 25475539 [TBL] [Abstract][Full Text] [Related]
8. Neonatal revaccination with Bacillus Calmette-Guérin elicits improved, early protection against Mycobacterium tuberculosis in mice. Li W; Huang H; Hua W; Ben S; Liu H; Xu B; Xian Q; Tang Z; Shen H Vaccine; 2012 May; 30(21):3223-30. PubMed ID: 22342709 [TBL] [Abstract][Full Text] [Related]
9. Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered. Dye C J R Soc Interface; 2013 Oct; 10(87):20130365. PubMed ID: 23904584 [TBL] [Abstract][Full Text] [Related]
13. Disseminated Bacille Calmette-Guérin infection at a glance: a mini review of the literature. Hassanzad M; Valinejadi A; Darougar S; Hashemitari SK; Velayati AA Adv Respir Med; 2019; 87(4):239-242. PubMed ID: 31476012 [TBL] [Abstract][Full Text] [Related]
14. Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial. Nissen TN; Birk NM; Kjærgaard J; Thøstesen LM; Pihl GT; Hoffmann T; Jeppesen DL; Kofoed PE; Greisen G; Benn CS; Aaby P; Pryds O; Stensballe LG Vaccine; 2016 May; 34(22):2477-82. PubMed ID: 27060379 [TBL] [Abstract][Full Text] [Related]
15. New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01 Clark RA; Weerasuriya CK; Portnoy A; Mukandavire C; Quaife M; Bakker R; Scarponi D; Harris RC; Rade K; Mattoo SK; Tumu D; Menzies NA; White RG BMC Med; 2023 Aug; 21(1):288. PubMed ID: 37542319 [TBL] [Abstract][Full Text] [Related]
16. [BCG vaccines for the prevention of tuberculosis in the world]. Hashimoto T Kekkaku; 1997 Nov; 72(11):629-37. PubMed ID: 9423301 [TBL] [Abstract][Full Text] [Related]
17. Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada. Deeks SL; Clark M; Scheifele DW; Law BJ; Dawar M; Ahmadipour N; Walop W; Ellis CE; King A Pediatr Infect Dis J; 2005 Jun; 24(6):538-41. PubMed ID: 15933565 [TBL] [Abstract][Full Text] [Related]
18. Safety and Immunogenicity of Early Bacillus Calmette-Guérin Vaccination in Infants Who Are Preterm and/or Have Low Birth Weights: A Systematic Review and Meta-analysis. Badurdeen S; Marshall A; Daish H; Hatherill M; Berkley JA JAMA Pediatr; 2019 Jan; 173(1):75-85. PubMed ID: 30476973 [TBL] [Abstract][Full Text] [Related]
19. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Colditz GA; Berkey CS; Mosteller F; Brewer TF; Wilson ME; Burdick E; Fineberg HV Pediatrics; 1995 Jul; 96(1 Pt 1):29-35. PubMed ID: 7596718 [TBL] [Abstract][Full Text] [Related]
20. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial. Rodrigues LC; Pereira SM; Cunha SS; Genser B; Ichihara MY; de Brito SC; Hijjar MA; Dourado I; Cruz AA; Sant'Anna C; Bierrenbach AL; Barreto ML Lancet; 2005 Oct; 366(9493):1290-5. PubMed ID: 16214599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]